ATE166925T1 - Nukleinsäure fragment des x-chromosomen bereichs beteiligt am empfindlichen x-syndrom, nukleotidische sonde und verfahren für die diagnose von geistiger zurückgebliebenheit mit empfindlichem x - Google Patents

Nukleinsäure fragment des x-chromosomen bereichs beteiligt am empfindlichen x-syndrom, nukleotidische sonde und verfahren für die diagnose von geistiger zurückgebliebenheit mit empfindlichem x

Info

Publication number
ATE166925T1
ATE166925T1 AT92907135T AT92907135T ATE166925T1 AT E166925 T1 ATE166925 T1 AT E166925T1 AT 92907135 T AT92907135 T AT 92907135T AT 92907135 T AT92907135 T AT 92907135T AT E166925 T1 ATE166925 T1 AT E166925T1
Authority
AT
Austria
Prior art keywords
nucleic acid
acid fragment
sensitive
hybridise
chromosome
Prior art date
Application number
AT92907135T
Other languages
English (en)
Inventor
Jean-Louis Mandel
Francois Rousseau
Anne Vincent
Dominique Heitz
Isabelle Oberle
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE166925T1 publication Critical patent/ATE166925T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92907135T 1991-02-13 1992-02-13 Nukleinsäure fragment des x-chromosomen bereichs beteiligt am empfindlichen x-syndrom, nukleotidische sonde und verfahren für die diagnose von geistiger zurückgebliebenheit mit empfindlichem x ATE166925T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9101684A FR2672618B1 (fr) 1991-02-13 1991-02-13 Fragment d'acide nucleique de la region du chromosome x implique dans le syndrome x fragile, sonde nucleotidique et procede pour le diagnostic du retard mental avec x fragile.

Publications (1)

Publication Number Publication Date
ATE166925T1 true ATE166925T1 (de) 1998-06-15

Family

ID=9409670

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907135T ATE166925T1 (de) 1991-02-13 1992-02-13 Nukleinsäure fragment des x-chromosomen bereichs beteiligt am empfindlichen x-syndrom, nukleotidische sonde und verfahren für die diagnose von geistiger zurückgebliebenheit mit empfindlichem x

Country Status (8)

Country Link
EP (1) EP0580621B1 (de)
JP (1) JPH06507310A (de)
AT (1) ATE166925T1 (de)
AU (1) AU671418B2 (de)
CA (1) CA2104110C (de)
DE (1) DE69225797T2 (de)
ES (1) ES2118130T3 (de)
FR (1) FR2672618B1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019058A1 (de) * 2000-04-06 2001-12-20 Epigenomics Ag Detektion von Variationen des DNA-Methylierungsprofils
US8679757B2 (en) 2009-03-24 2014-03-25 Asuragen, Inc. PCR methods for characterizing the 5′ untranslated region of the FMR1 and FMR2 genes
ES2759023T3 (es) 2012-07-20 2020-05-07 Asuragen Inc Genotipificación completa de FMR1
CN110923305B (zh) * 2019-11-25 2023-12-29 广州市达瑞生物技术股份有限公司 一种适用于脆性X综合征southern blot印迹杂交检测的DNA分子量标准

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2578847A1 (fr) * 1985-03-13 1986-09-19 Centre Nat Rech Scient Sonde adn destinee au diagnostic antenatal de certaines anomalies chromosomiques
GB8825530D0 (en) * 1988-11-01 1988-12-07 Medical Res Council Probe
GB8928029D0 (en) * 1989-12-12 1990-02-14 Medical Res Council Probe
CA2094938A1 (en) * 1991-01-04 1992-07-05 Grant R. Sutherland Dna sequences related to isolated fragile x syndrome

Also Published As

Publication number Publication date
AU1413692A (en) 1992-09-15
EP0580621B1 (de) 1998-06-03
EP0580621A1 (de) 1994-02-02
CA2104110A1 (fr) 1992-08-14
ES2118130T3 (es) 1998-09-16
DE69225797T2 (de) 1999-02-04
CA2104110C (fr) 2003-12-09
FR2672618B1 (fr) 1994-12-02
JPH06507310A (ja) 1994-08-25
DE69225797D1 (de) 1998-07-09
FR2672618A1 (fr) 1992-08-14
AU671418B2 (en) 1996-08-29

Similar Documents

Publication Publication Date Title
Bell et al. Functional cooperativity between transcription factors UBF1 and SL1 mediates human ribosomal RNA synthesis
Watanabe et al. Primary and higher order structures of nematode (Ascaris suum) mitochondrial tRNAs lacking either the T or D stem.
Freking et al. Identification of the single base change causing the callipyge muscle hypertrophy phenotype, the only known example of polar overdominance in mammals
Schaufele et al. Overlapping Pit-1 and Sp1 binding sites are both essential to full rat growth hormone gene promoter activity despite mutually exclusive Pit-1 and Sp1 binding.
McLAUCHLAN et al. Organization of the herpes simplex virus type 1 transcription unit encoding two early proteins with molecular weights of 140000 and 40000
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DE69534733D1 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
ATE352638T1 (de) REVERSE ßTWO-HYBRIDß-SYSTEME
Zhou et al. Mapping of the human RNASEL promoter and expression in cancer and normal cells
Sypes et al. Protein/DNA crosslinking of a TFIID complex reveals novel interactions downstream of the transcription start
Margarit et al. Identification of conserved potentially regulatory sequences of the SRY gene from 10 different species of mammals
ATE293633T1 (de) Hypoxie-regulierte gene
DE69738804D1 (de) Blütenorgan-spezifische promotersequenzen
Selker et al. An upstream signal is required for in vitro transcription of Neurospora 5S RNA genes
EP0973794A4 (de) Netrinrezeptoren
Sapp et al. A newly detected class of mammalian single strand-specific DNA-binding proteins. Effects on DNA polymerase alpha-catalyzed DNA synthesis.
Sheng et al. Structure, sequence, and promoter analysis of human disabled-2 gene (DAB2)
ATE166925T1 (de) Nukleinsäure fragment des x-chromosomen bereichs beteiligt am empfindlichen x-syndrom, nukleotidische sonde und verfahren für die diagnose von geistiger zurückgebliebenheit mit empfindlichem x
Van Damme et al. Stimulation of fibroblast interferon production by a 22K protein from human leukocytes
FR2679253B1 (fr) Proteines de resistance a la cycloheximide. utilisation comme marqueur de selection par exemple pour controler le transfert d'acides nucleiques.
Gutiérrez et al. Signals in the φ29 DNA-terminal protein template for the initiation of phage φ29 DNA replication
Miller et al. A transcriptionally active pseudogene in xenopus laevis oocyte 5S DNA
Kothary et al. IS186: an Escherichia coli insertion element isolated from a cDNA library
Tee et al. Temperature gradient gel electrophoresis: detection of a single base substitution in the cattle β‐lactoglobulin gene
Stanford et al. DNA sequence of a human Sm autoimmune antigen. The multigene family contains a processed pseudogene.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties